BIOCHEMICAL SOCIETY TRANSACTIONS
VOL . 27 , NO . 1 1999
667th Leicester Meeting
A1 Trimeric G-proteins: structure, mechanism and regulation
P.B. Sigler 1
A2 Time-resolved crystallography of protein intermediates
K. Moffat 1
A3 Protein kinase structure and mechanism
L. Johnson 1
A4 Single molecule enzyme kinetics: application to myosin ATPases
C.R. Bagshaw 2
A5 The structure of bovine mitochondrial F1ATPase: an example of rotary catalysis
A.G.W. Leslie 2
A6 Time-resolved intermediate trapping and X-ray crystallographic studies of enzyme
mechanism: isocitrate dehydrogenase and nuclease catalysts
B.L. Stoddard 2
A7 Galactose and amine oxidases: making the most of tyrosine residues
S. Phillips 2
A8 Antibiotics and CoA enzymology: some useful connections
B. Shaw 3
A9 The enzymology of polyketide antibiotic biosynthesis
P.F. Leadlay 3
A 10 DNA gyrase as a drug target
A. Maxwell 3
A11 Dihydropteroate synthase: an old drug target revisited
J.P, Derrick 3
A12 Penicillin and cephalosporin biosynthesis
J. Hajdu 4
A13 Mechanistic diversity of p-lactamases
J.-M. Frere 4
A 14 Protein antibiotics and their inhibition
C. Kleanthous 4
B I The maternal, fetal and postnatal somatotrophic axes in intra-uterine growth retardation
P. Gluckman 4
B2 Control of fetal growth by genomic imprinting
W. Reik 5
B3 Perinatal hormone levels and their role in normal/abnormal development and function
of the male reproductive system 5
R. Sharpe
B4 Gender-specific brain formation of oestrogen in behavioural development 5
J.B. Hutchinson
B5 Glucocorticoids and fetal programming 5
J.R. Seckl
B6 Genetic dissection of glucocorticoid receptor function 6
H. Reichardt
B7 Early environmental events regulate neuroendocrine development 6
M. Meaney
B8 Deiodinase protection of the fetus from thyroid hormones 6
D.L. St Germain
B9 Intra-uterine programming of hypertension: the role of the renin-angiotensin system 6
S.C. Langley-Evans
BIO Neuroendocrine adaptations of the fetus to nutrient restriction 7
LC. McMillen
B 11 Programming of hepatic and peripheral tissue insulin sensitivity by maternal protein 7
restriction
S.E. Ozanne
B12 Maternal nutrition and endocrine programming of fetal adipose tissue development 7
M.E. Symonds
BIS Pre-adrenarche androgens and glucocorticoids and blood pressure control 7
J. Honour
B14 Fetal programming of adult diseases 8
D. Barker
Cl Overview of the biochemistry curriculum
E.J. Wood 8
C2 Core biochemistry: the Society's view
J.M. Wrigglesworth 8
C3 Core biochemistry: a European perspective
J. Aghion 8
C4 Core biochemistry: lessons from biological sciences
L. Jervis 9
C5 Core biochemistry: the necessity for chemistry
R.J.H. Davies 9
C6 Core biochemistry: an industrial perspective
D. Boxer 9
C7 Core biochemistry: a pharmaceutical industry perspective
M.J.B. Brown 9
Dl Properties of the hyaluronan synthase from Group A Streptococcus pyogenes
P.H. Weigel 10
D2 Mammalian hyaluronan synthases: investigation of functional relationships in vivo
A.P. Spicer 10
D3 Mammalian hyaluronan synthases and their functions
N. Itano 10
D4 Colon-derived smooth-muscle cells treated with double-stranded RNA (poly 1:C)
increase adherence of mononuclear leucocytes via hyaluronan-CD44 interactions
V.C. Hascall 10
D5 Structural regulation of hyaluronan binding to proteins
A.J. Day 11
D6 The conformations of hyaluronan in aqueous solution: comparison of theory and
experiment
J. Sheehan 11
D7 New approaches to the investigation of hyaluronan networks
T. Hardingham 11
D8 Biomedical applications of hyaluronan
E. Balazs 11
D9 Hyaluronan in embryogenesis
C. Archer 12
DIO Hyaluronan injoint cavitation
A.A. Pitsillides 12
Dll Hyaluronan receptors: the regulation of the cytoskeleton and their impact on skin
wound
E. Turley 12
D12 The chondrocyte pericellular matrix: a model for hyaluronan-mediated cell-matrix
interactions
C.B. Knudson 12
D13 TSG-6: a hyaladherin associated with inflammation
H.-G. Wisniewski 13
D14 Mode of action of hyaluronate enhancement of haemopoiesis
H. Ponta 13
El Introduction: importance of oestrogen, xenoestrogen and phytoestrogen metabolism in
breast cancer risk?
H. Wiseman 13
E2 Oestrogen and phytoestrogen metabolism: role of the gut microflora
1. Rowland 13
E3 Phytoestrogens in human milk and other biomatrices
A.A. Franke 14
E4 Phytoestrogen sulphoconjugates as inhibitors of sterol sulphatase
W.M. Keung 14
E5 4-Hydroxylation of oestrogens as a marker of breast cancer risk
J.G. Liehr 14
E6 Aromatase and breast cancer risk
M. Dowsett 14
E7 Regulation ofsteroid sulphatase and oestradiol 173-hydroxysteroid dehydrogenase in
breast cancer
M.J. Reed 15
Fl Metabolic pathway engineering of plant secondary metabolites
A.J. van Tunen
F2 Genetic engineering of plant secondary metabolism using particle bombardment
M.J. Leech 15
p3 Micromanipulation measurement of plant cell mechanical properties
C.R. Thomas 15
p4 Competitive production systems: cost/benefit/scale effects
P. Lapinskas 16
F5 Ascorbate: the light in mid-pathway
N. Smirnoff 16
F6 Special effects from plants
D.W.M. Smiley 16
F7 Flavonoids: antioxidants in vino veritas or the cup that cheers?
A. Crozier 16
F8 Manipulating the glucosinolate content of Brassicas
R. Mithen 17
F9 Fatty acid oxidation; tasteful tunes played on the green notes
R. Casey 17
FIO The terpenoid pathway: closing the loop
M.H. Beale 17
Fl I Genetic engineering of the plant isoprenoid pathway: all things considered?
T.J. Bach 17
F12 Checks and balances in the lipid pathways/network
T. Slabas 18
F13 Turnover and sequestration of plant secondary products
R. Edwards 18
F14 Forging the link; international networking
I.D.G. Bartle 18
Gl Live control of the living cell
H.V. Westerhoff 18
G2 Design of gene circuitry by natural selection: analysis of the lactose catabolic system in
Escherichia coli
M.A. Savageau 19
G3 Theoretical studies on how ATP supply meets ATP consumption
B. Korzeniewski 19
G4 New insights into metabolic pathway optimization by analogy with industrial
manufacturing processes
M.Cascante 19
G5 Enzyme kinetics from a metabolic perspective
A. Cornish-Bowden 19
G6 Modelling lipid metabolism in plants: a slippery problem?
J.L. Harwood 20
G7 Modelling metabolism in vivo: approaches using NMR
R.A. lies 20
G8 Control and structural design of glycolysis: an evolutionary approach
R. Heinrich 20
G9 Traditional concepts of metabolic control mislead more than enlighten
D.A. Fell 20
GIO Using practicals to teach metabolic control analysis (MCA): a worked example
P. Quant 21
Gil Towards understanding the extras of metabolic pathways: the implementation of
quantitative analyses
J.L. Snoep 21
G12 Kinetics for the numerically challenged
K.F. Tipton 21
G13 Using computers to learn about metabolism
P. Mendes 21
G14 Mrs. Spratt, young penguins and drunken elephants: teaching metabolic regulation in
relation to health and disease requires a whole-body approach
M. Watford 22
G15 Applying the learning: the case for teaching in industry
D. Myles 22
G16 Overview: linking research and teaching
M. Brand 22
HI Shedding of the interleukin-6 receptor: mechanisms and physiological consequences
S. Rose-John 22
H2 Characterization of the tumour-necrosis-factor (TNF (alpha)-converting enzyme
proteins
D.R Cerretti 23
H3 Interleukin-6 receptor shedding: a role for members of the ADAM (a disintegrin and I
metalloproteinase-like) family
P.I. Croucher 21
H4 Angiotensin-converting enzyme and the amyloid precursor protein secretases
N.M. Hooper 23
H5 Proteolytic processing of (beta)-amyloid precursor protein and presenilins
H. Steiner
mechanismss controllins the shedding of transmembrane molecules
J.arribas 24
activated receptors: novel functions for serine proteases
MicU 24
ADAMs (a disintegrin and metalloproteinase-like) proteinases as membrane
protoin secratases
A.J.TUNER 24
J4 Multichannel affinity sensors for environmental monitoring
D.C. Cullen 27
J5 Biacore: an affinity biosensor for characterization of biomolecular interactions
M. Malmqvist 28
J6 Cholera toxin and GM1:a model membrane study of lAsy
C.H. Maule 28
J7 Molecular imprinted biosensors
K. Mosbach 28
J8 Holographic biosensors
C.R. Lowe 28
Kl Flavocytochromes: structures and implications for electron transfer
F.S. Mathews 29
K2 Flavocytochromes: transceivers and relays in biological electron transfer
S.K. Chapman 29
K3 Structural studies of the flavoprotein reductase component of the P-450 mono-
oxygenase system
G.C.K. Roberts 29
K4 Flavocytochrome P-450 BM3: electron transfer and its control in a model P-450
A.W.Munro 29
K5 Electron transfer in trimethylamine dehydrogenase and electron-transferring
flavoprotein
N.S.Scrutton 30
K6 Methylamine dehydrogenase: structure and function of electron-transfer complexes
V.L. Davidson 30
K7 Ribonucleotide-reductase-coupled electron-/proton-transfer mechanisms
B.M. Sjoberg
K8 Pyrroloquinoline quinone (PQQ)-dependent methanoi dehydrogenase and glucose .
dehydrogenase
C. Anthony 31
______________________________________________
E5 Phosphoinositide 3-kinase knock-out mice: role of p85oc in B cell development and
proliferation
A. Fruman 73
E6 The role of phosphoinositide 3-kinase in the regulation of cell survival and apoptosis
J. Downward 74
E7 Phosphoinositide 3-kinase signalling: no lipids
M.P. Wymann 74
E8 Mechanisms of COPI-vesicle biogenesis
F. Wieland 74
E9 Lipid-protein interactions in the biogenesis of neurosecretory vesicles
W.B. Huttner 74
E 10 Intracellular transport and organelle morphology in cell lines with inducible
overexpression ofphospholipase D I (PLDI) or of a PLD I-derived antisense fragment
N. Ktistakis 75
E11 The small GTPase ADP-ribosylation factor (ARF) regulates phosphoinositide 4-kinase
P in the Golgi complex
M.A. De Matteis 75
E 12 ADP-ribosylation factor (ARF), a multi-functional GTPase as a co-ordinator of
membrane traffic: is ARF-regulated phospholipase D the answer to everything?
S. Cockcroft 75
E 13 Phosphoinositides and neurotransmitter release
G. Schiavo 75
E14 Phospholipase C-§ and related molecules
H. Yagisawa 76
E 15 Localization and regulation of type II PIPkins (Ptdlns5P 4-kinases)
R.F. Irvine 76
E 16 Regulation of early endosome dynamics by early endosomal antigen-1 (EEAI): a
phosphatidylinositol 3-phosphate-binding protein
M.J. Clague 76
E 17 Regulation of endocytic membrane traffic by phosphatidylinositol 3-phosphate
H. Stenmark 76
E 18 Lipid kinases and trans-Golgi network membrane dynamics
S.Ponnambalam 77
E 19 Phosphatidylinositol 3,5-bisphosphate: a novel inositol lipid linking stress responses to
membrane trafficking in yeast
S.K. Dove 77
E20 Analysis of protein and vesicle trafficking using green fluorescent protein
J.M. Tavare 77
E21 Role for ADP-ribosylation factors and phosphoinositides in insulin-regulated
membrane trafficking in 3T3-LI adipocytes
G.W. Gould 77
E22 Phosphoinositide 3-kinase effector molecules
P.J. Cullen 78
_______________________________________________
BIOCHEMICAL SOCIETY TRANSACTIONS
VOL. 27, NO. 2, 1999
Single molecule enzyme kinetics: applications to C. R. BAGSHAW AND P. B. CONIBEAR 33
myosin ATPases
The structure of bovine mitochondrial Fi-ATPase: an A. G. W. LESLIE, J. P. ABRAHAMS, K. BRAIG, R. LUTTER, 37
example of rotary catalysis R. I MENZ, G. L. ORRISS, M. J. VAN RAAIJ AND
J. E. WALKER
Visualizing enzyme intermediates using fast B. L. STODDARD 42
diffraction and reaction trapping methods: isocitrate
dehydrogenase
DNA gyrase as a drug target A. MAXWELL 48
Dehydropteroate synthase: an old drug revisited H. G. VINNICOMBE AND J. P. DERRICK 53
Mechanistic diversity of beta -lactamases J.-M. FRERE, A. DUBUS, M. GALLENI, A. MATAGNE AND 58
G.AMICOSANTE
Protein antibiotics and their inhibitors G. KLEANTHOUS, R. JAMES, A. M. HEMMINGS AND 63
G. R. MOORE
colloquium: Endocrine Control of Perinatal Programming in Health and
Disease
The maternal, fetal and postnatal somatographic M. H. OLIVER, F. H. BLOOMFIELD, J. E. HARDING, 69
axes in intrauterine growth retardation B. H. BREIER, N. S. BASSETT AND P. D. GLUCKMAN
Glucocorticoids and fetal programming J. R. SECKL, M. J. NYIRENDA, B. R. WALKER AND 74
K. E. CHAPMAN
The Cre/loxP system - a versatile tool to study H. M. REICHARDT. C. KELLENDONK, F. TRONCHE AND 78
glucocorticoid signalling in mice G. SCHÜTZ
Development effects of thyroid hormone: the role of D. L. ST. GERMAIN 83
deiodinases m regulatory control
Intrauterine programming of hypertension: the role S. C. LaNGLEY-EVANS, R. C. SHERMAN, - 88
of the renin-angiotensin system S. J. M. WELHAM, M. 0. NWAGWU, D. S. GARDNER
AND A. A. JACKSON
Programming of hepatic and peripheral tissue insulin S. E. OZANNE 94
sensitivity by maternal protein restriction
Maternal nutrition and endocrine programming of M. E. SYMONDS AND T. STEPHENSON 97
fetal adipose tissue development
colloquium: The Biology of Hyaluronan
Properties of the hyaluronan synthase from Group A V. L. TLaPAK-SIMMONS, C. HELDERMON, 105
Streptococcus pyogenes E. S. KEMPNER AND P. H. WEIGEL
Mammalian hyaluronan synthases: investigation of A. P. SPICER AND T. K. NGUYEN 109
functional relationships in vivo
The structure and regulation of hyaluronan-binding A. J. DAY 1 15
proteins
The conformations of hyaluronan in aqueous J. SHEEHAN, A. BRASS AND A. ALMOND 121
solution: comparison of theory and experiment
New approaches to the investigation of hyaluronan T. HARDINGHAM, B. C. HENG AND P. GRIBBON 124
networks
Hyaluronan in Joint cavitation A. C. WARD, G. P. DOWTHWAITE AND 128
A. A. PITSILLIDES
Receptor for hyaluronan-mediated motility W.-F. CHEUNG, T. F. CRUZ AND E. A. TURLEY 135
(RHAMM), a hyaladherin that regulates cell
responses to growth factors
The chondrocyte pericellular matrix: a model for . C. B. KNUDSON, G. A. NOFAL, L. PAMINTUAN AND 142
hyaluronan-mediated cell-matrix interactions D. J. AGUIAR
colloquium: G-Protein-Coupled Receptor Signalling in the CentralNervous System
Diversity in the signalling and regulation of G. MILUGAN, D. A. GROARKE, A. MCLEAN, R. WARD, 149
G-protein-coupled receptors C. W. FONG, A. CAVALLI AND T. DRMOTA
Regulatory mechanisms of alfa lb iB-adrenergic receptor S. GOTECCHIA AND S. MHAOUTY-KODJA 154
function
Promiscuity and fidelity in receptor-G-protein F. KALKBRENNER, A. ABEL, N. WITTAU AND 158
coupling: cell cycle-dependent coupling of the G. SCHULTZ
vasopressin Vi receptor
Heterologous mammalian expression systems for E. HERMANS, S. R. NAHORSKI AND R. A. J. GHALUSS 164
investigating the properties of metabotropic
glutamate receptors
Evidence that a novel metabotropic glutamate Z. A. BORTOLOTTO AND G. L. COLUNGRIDGE 170
receptor mediates the induction of long-term
potentiation at CA I synapses in the hippocampus
Mechanisms of action of anti-psychotic drugs P. G. STRANGE 175
colloquium: Enzyme-Catalysed Electron/Radical Transfer
Flavocytochromes: structures and implications for L. M. CUNANE. Z.-W. CHEN, R. C. E. DURLEY, 179
electron transfer J. D. BARTON AND F. S. MATHEWS
Flavocytochromes: transceivers and relays in S. K. CHAPMAN, F. WELSH, K MOYSEY, C. MOWAT, 185
biological electron transfer M. K. DOHERTY, K. L. TURNER, A. W. MUNRO AND
G. A. REID
Flavocytochrome P-^O BM3: a paradigm for the A. W. MUNRO, M. A. NOBLE, C. S. MILES, 190
analysis of electron transfer and its control in the S. N. DAFF, A. J. GREEN, L. QUARONI, S. RIVERS,
p-450s T. W. B. OST, G. A. REID AND S. K. CHAPMAN
Electron transfer in trimethylamine dehydrogenase N. S. SCRUTTON, J. BASRAN, E. K. WILSON, 196
and electron-transferring flavoprotein K. K. CHOHAN, M.-H. JANG, M. J. SUTCLIFFE AND
R. HILLE
Methylamine dehydrogenase: structure and function V. L. DAVIDSON 201
of electron transfer complexes
Electron transfer and coupled processes in protein F. A. ARMSTRONG 206
film voltammetry
colloquium: Membrane Protein Secretases
Generation and function of the soluble interleukin-6 J. MÜLLBERG, P. VOLLMER, K. ALTHOFF, P. MÄRZ AN D 211
receptor S. ROSE-JOHN
Characterization of the tumour necrosis factor D. P. CERRETTI 219
converting enzyme, TACE/ADAM 17
lntcrteukin-6 receptor shedding: a posrofor P. I. CROUCHER, F. WANG AND P. G. HARGREAVES 224
members of the ADAM family
Angiotensin-converting enzyme and the amyloid N. M. HOOPER, S. PARVATHY. E. H. KARRAN AND 229
P^cursor protein secretases A.J.TURNER
^oteolytic processing and degradation of H. STEINER, A. CAPELL AND C. HAASS 234
Mfhuiner^ disease relevant proteins
mechanisms controlling the shedding of A. MERLOS-SUÄREZ AND J. ARRIBAS 243
transmembrane molecules
Proteinas-activated receptors: a growing family of O.DERY AND N. W. BUNNETT 246
heptahelical receptors for thrombin, trypsin and
tryptase
Role for ADAM -family proteinases as membrane A. J. TURNER AND N. M. HOOPER 255
Live control of the living cell W. C. VAN HEESWIJK, B. M. BAKKER, B. TEUSINK, 261
B. N. KHOLODENKO, 0. J. G. SOMSEN, J. L. SNOEP
AND H. V. WESTERHOFF
Design of gene circuitry by natural selection: analysis M.A.SAVAGEAU 264
of the lactose catabolic system in Escherichio coli
Theoretical studies on how ATP supply meets ATP B. KORZENIEWSKI 271
demand
New insights into metabolic pathway optimization F. ORTEGA, E. MARTI AND M. CASCANTE 276
by analogy with industrial manufacturing processes
Enzyme kinetics from a metabolic perspective A. CORNISH-BOWDEN 281
Modelling lipid metabolism in plants: a slippery J. L. HARWOOD, U. S. RAMU, R. A. PAGE AND 285
problem? P. A. QUANT
Modelling metabolism in vivo: approaches using NMR R. A. ILES, J. S. BEECH, S. P. BURNS AND R. D. COHEN 289
The structural design ofglycolysis: an evolutionary R. HEINRICH. E. MELENDEZ-HEVIA, F. MONTERO, 294
approach J. C. NUNO, A. STEPHANI AND T. G. WADDELL
colloquium: Oestrogen Metabolism and Breast Cancer Risk
Importance of oestrogen,xenoestrogen and H.WISEMAN 299
phytoestrogen metabolism in breast cancer risk
Metabolism ofoestrogens and phytoestrogens: role I. ROWLAND, H. WISEMAN, T. SANDERS, 304
of the gut microflora H. ADLERCREUTZ AND E. BOWEY
Phytoestrogens in human biomatrices including A. A. FRANKE, M. C. Yu, G. MASKARINEC, P. FANTI, 308
breast milk W. ZHENG AND L. J. CUSTER
4-Hydroxylation of oestrogens as a marker for J. G. LIEHR 318
mammary tumours
Regulation of steroid sulphatase and oestradiol A. PUROHIT, A. SINGH AND M. J. REED 323
17 beta -hydroxysteroid dehydrogenase in breast cancer
colloquium: Biosensors: Into the 21st Century
Analysis of structure-activity relationships with M. H. V. VAN REGENMORTEL 329
biosensors
Biosensors: past, present and future H.A. 0. HILL AND J.J.DAVIS 331
BIACORE: an affinity biosensor system, for M. MALMQVIST 335
characterization of biomolecular interactions
Cholera toxin and G (MI ) a model membrane study N. ATHANASSOPOULOU, R. J. DAVIES, P. R. EDWARDS, 340
with lAsys D. YEUNG AND C. H. MAULE
Molecularly imprinted polymers in chemical and K. HAUPT AND K. MOSBACH 344
biological sensing
LI From genomics to aetiology in the multifactorial disease type-1 diabetes
J.A. Todd 1
AI Trimeric G-proteins: structure, mechanism and regulation
P.B. Sigler 1
A2 Time-resolved crystallography of protein intermediates
K. Moffat 1
A3 Protein kinase structure and mechanism
L. Johnson 1
A4 Single molecule enzyme kinetics: application to myosin ATPases
C.R. Bagshaw 2
A5 The structure of bovine mitochondrial F1ATPase: an example of rotary catalysis
A.G.W. Leslie 2
A6 Time-resolved intermediate trapping and X-ray crystallographic studies of enzyme
mechanism: isocitrate dehydrogenase and nuclease catalysts
B.L. Stoddard 2
A7 Galactose and amine oxidases: making the most of tyrosine residues
S. Phillips 2
A8 Antibiotics and CoA enzymology: some useful connections
B. Shaw 3
A9 The enzymology of polyketide antibiotic biosynthesis
P.F. Leadlay 3
A 10 DNA gyrase as a drug target
A. Maxwell 3
All Dihydropteroate synthase: an old drug target revisited
J.P. Derrick 3
A 12 Penicillin and cephalosporin biosynthesis
J. Hajdu 4
Al 3 Mechanistic diversity of p-lactamases 4
J.-M. Frère
A 14 Protein antibiotics and their inhibition 4
C. Kleanthous
B I The maternal, fetal and postnatal somatotrophic axes in intra-uterine growth retardation 4
P. Gluckman
B2 Control of fetal growth by genomic imprinting 5
W. Reik
B3 Perinatal hormone levels and their role in normal/abnormal development and function 5
of the male reproductive system
R. Sharpe
B4 Gender-specific brain formation of oestrogen in behavioural development 5
J.B. Hutchinson
B5 Glucocorticoids and fetal programming 5
J.R. Seckl
B6 Genetic dissection of glucocorticoid receptor function 5
H. Reichardt
B7 Early environmental events regulate neuroendocrine development 6
M. Meaney
B8 Deiodinase protection of the fetus from thyroid hormones 6
D.L. St Germain
B9 Intra-uterine programming of hypertension: the role of the renin-angiotensin system 6
S.C. Langley-Evans
BIO Neuroendocrine adaptations of the fetus to nutrient restriction 7
LC. McMillen
B 11 Programming of hepatic and peripheral tissue insulin sensitivity by maternal protein 7
restriction
S.E. Ozanne
B12 Maternal nutrition and endocrine programming of fetal adipose tissue development 7
M.E. Symonds
B13 Pre-adrenarcheandrogens and glucocorticoids and blood pressure control 7
J. Honour
B14 Fetal programming of adult diseases 8
D. Barker
Cl Overview of the biochemistry curriculum
E.J. Wood 8
C2 Core biochemistry: the Society's view
J.M. Wrigglesworth 8
C3 Core biochemistry: a European perspective
J. Aghion 8
C4 Core biochemistry: lessons from biological sciences
L. Jervis 9
C5 Core biochemistry: the necessity for chemistry
R.J.H. Davies 9
C6 Core biochemistry: an industrial perspective
D. Boxer 9
C7 Core biochemistry: a pharmaceutical industry perspective
M.J.B. Brown 9
Dl Properties of the hyaluronan synthase from Group A Streptococcus pyogenes
P.H. Weigel 10
D2 Mammalian hyaluronan synthases: investigation of functional relationships in vivo
A.P. Spicer 10
D3 Mammalian hyaluronan synthases and their functions
N. Itano 10
D4 Colon-derived smooth-muscle cells treated with double-stranded RNA (poly 1:C)
increase adherence of mononuclear leucocytes via hyaluronan-CD44 interactions
V.C. Hascall 10
D5 Structural regulation of hyaluronan binding to proteins
A.J. Day 11
D6 The conformations of hyaluronan in aqueous solution: comparison of theory and
experiment
J. Sheehan 11
D7 New approaches to the investigation of hyaluronan networks
T. Hardingham 11
D8 Biomedical applications of hyaluronan
E. Balazs 11
D9 Hyaluronan in embryogenesis
C. Archer 12
DIO Hyaluronan injoint cavitation
A.A. Pitsillides 12
DU Hyaluronan receptors: the régulation of the cytoskeleton and their impact on skin
wound
E. Turley 12
D12 The chondrocyte pericellular matrix: a model for hyaluronan-mediated cell-matrix
interactions
C.B. Knudson 12
D13 TSG-6: a hyaladherin associated with inflammation
H.-G. Wisniewski 13
D14 Mode of action othyaluronate enhancement ofhaemopoiesis
H. Ponta 13
El Introduction: importance of oestrogen, xenoestrogen and phytoestrogen metabolism in
breast cancer risk?
H. Wiseman 13
E2 Oestrogen and phytoestrogen metabolism: role of the gut microflora
1. Rowland 13
E3 Phytoestrogens in human milk and other biomatrices
A.A. Franke 14
E4 Phytoestrogen sulphoconjugates as inhibitors of sterol sulphatase
W.M. Keung 14
E5 4-Hydroxylation of oestrogens as a marker of breast cancer risk
J.G. Liehr 14
E6 Aromatase and breast cancer risk
M. Dowsett 14
E7 Regulation ofsteroid sulphatase and oestradiol 173-hydroxysteroid dehydrogenase in
breast cancer
M.J. Reed 15
FI Metabolic pathway engineering of plant secondary metabolites
A.J. van Tunen
F2 Genetic engineering of plant secondary metabolism using particle bombardment
M.J. Leech 15
F3 Micromanipulation measurement of plant cell mechanical properties
C.R. Thomas 15
F4 Competitive production systems: cost/benefit/scale effects
P. Lapinskas 16
F5 Ascorbate: the light in mid-pathway
N. Smirnoff 16
F6 Special effects from plants
D.W.M. Smiley 16
F7 Flavonoids: antioxidants in vino veritas or the cup that cheers?
A. Crozier 16
F8 Manipulating the glucosinolate contentof Brassicas
R. Mithen 17
F9 Fatty acid oxidation; tasteful tunes played on the green notes
R. Casey 17
F10 The terpenoid pathway: closing theloop
M.H. Beale 17
F11 Genetic engineering of the plant isoprenoid pathway: all things considered?
T.J. Bach 17
F12 Checks and balances in the lipid pathways/network
T. Slabas 18
F 13 Turnover and sequestration of plant secondary products
R. Edwards 18
F14 Forging the link; international networking
I.D.G. Bartle 18
G1 Live control of the living cell
H.V. Westerhoff 18
G2 Design of gene circuitry by natural selection: analysis of the lactose catabolic system in
Esch erichia coli
M.A. Savageau 19
G3 Theoretical studies on how ATP supply meets ATP consumption
B. Korzeniewski 19
G4 New insights into metabolic pathway optimization by analogy with industrial
manufacturing processes
M.Cascante 19
G5 Enzyme kinetics from a metabolic perspective
A. Cornish-Bowden 19
G6 Modelling lipid metabolism in plants: a slippery problem?
J.L. Harwood 20
G7 Modelling metabolism in vivo: approaches using NMR
R.A. lies 20
G9 Traditional concepts of metabolic control mislead more than enlighten
D.A. Fell 20
G10 Using practicals to teach metabolic control analysis (MCA): a worked example
P. Quant 21
G11 Towards understanding the extras of metabolic pathways: the implementation of
quantitative analyses
J.L. Snoep 21
G 12 Kinetics for the numerically challenged
K.F.Tipton 21
G 13 Using computers to learn about metabolism
P. Mendes 21
G 14 Mrs. Spratt, young penguins and drunken elephants: teaching metabolic regulation in I
relation to health and disease requires a whole-body approach
M. Watford 22
G 15 Applying the learning: the case for teaching in industry
D. Myles 22
G 16 Overview: linking research and teaching
M. Brand 22
H1 Shedding of the interleukin-6 receptor: mechanisms and physiological consequences
S. Rose-John 22
H2 Characterization of the tumour-necrosis-factor (TNFcx)-converting enzyme
[(TACE)/ADAM17]-deficient mouse and its role in the shedding of cell-surface
proteins
D.P. Cerretti 23
H3 Interleukin-6 receptor shedding: a role for members of the ADAM (a disintegrin and
metalloproteinase-like) family
P.I. Croucher 23
H4 Angiotensin-converting enzyme and the amyloid precursor protein secretases
N.M. Hooper 23
H5 Proteolytic processing of (beta)-amyloid precursor protein and presenilins
H. Steiner 23
H6 Mechanisms controlling the shedding oftransmeinbrane molecules
J. Arribas 24
H7 Protease-activated receptors: novel functions for serine proteases
N.W. Bunnett 24
H8 A role for ADAMs (a disintegrin and metalloproteinase-like) proteinases as membrane
protein secretases
A.J. Turner 24
11 Diversity in the signalling and regulation of G-protein-coupled receptors
G. Milligan 24
12 Metabotropic glutamate receptor signalling
E. Hermans 25
13 Acute and chronic regulation by G-protein-coupled receptors
S. Cotecchia 25
14 Involvement of the N-terminus of neuronal calcium channels in G-protein modulation
A.C. Dolphin 25
15 Cell-cycle-dependent coupling of vasopressin V1-receptor to G q/11 and Gi3
F. Kalkbrenner 25
16 Organization of G-protein-coupled receptors and ion channels at the synapse
P. Somogyi 26
17 Role of G-protein-coupled receptors in adaptative neuronal processes
G.L. Collingridge 26
18 Clinical exploitation of 5-hydroxytryptamine receptor diversity
D. Hoyer 26
19 Dopamine receptor antagonists or inverse agonists as anti-psychotics?
P.G. Strange 26
Jl Analysis of structure-activity relationships with biosensors
M.H.V. Van Regenmortal 27
J2 Design of molecular biosensor surfaces for screening ligand-receptor interactions by
functional assay
H. Vogel 27
J3 Biosensors: past, present and future
H.A.O. Hill 27
J4 Multichannel affinity sensors for environmental monitoring
D.C. Cullen 27
J5 Biacore: an affinity biosensor for characterization of biomolecular interactions
M. Malmqvist 28
J6 Cholera toxin and G M1: a model membrane study of lAsys
C.H. Maule 28
J7 Molecular imprinted biosensors
K. Mosbach 28
J8 Holographic biosensors
C.R. Lowe 28
Kl Flavocytochromes: structures and implications for electron transfer
F.S. Mathews 29
K2 Flavocytochromes: transceivers and relays in biological electron transfer
S.K. Chapman 29
K3 Structural studies of the flavoprotein reductase component of the P-450 mono-
oxygenase system
G.C.K. Roberts 29
K4 Flavocytochrome P-450 BM3: electron transfer and its control in a model P-450
A.W.Munro 29
K5 Electron transfer in trimethylamine dehydrogenase and electron-transferring
flavoprotein
N.S.Scnitton 30
K6 Methylamine dehydrogenase: structure and function of electron-transfer complexes
V.L. Davidson 30
K7 Ribonucleotide-reductase-coupled electron-/proton-transfer mechanisms
B.M. Sjoberg 30
K8 Pyrroloquinoline quinone (PQQ)-dependent methanoi dehydrogenase and glucose
dehydrogenase
C* Anthony 30
K9 Galactose oxidase and topaquinone (TPQ)-dependent amine oxidase
P. Knowles 31
KIO Electron transfer and coupled processes in protein film voltammetry
F.A. Armstrong 31
1 Problem-based learning: scaling-up issues
L. Jervis 31
2 The effect of site-directed mutagenesis of two transmembrane serine residues on
agonist-specific coupling of a cloned human (alpha)2A-adrenergic receptor
J.E. Rudling and P.D. Evans 31
3 Muscarinic receptor (M^-evoked increase in [Ca2+] i in SH _SY5Y cells inhibits
noradrenaline release
D.J. Roberts, C. Peers and P.F.T. Vaughan 32
4 Characterization of purinoceptor-mediated Ca2+ oscillations in L-fibroblasts
R.J. Davis, R.A.J. Challiss and S.R. Nahorski 32
5 Cultured spinal cord cells take up and release pH]noradrenaline: evidence for intrinsic
noradrenergic neurons
J.R. Purkiss, L.M. Fris, S. Doward and C.P. Quinn 32
6 How does the internalization of G-protein-coupled receptor agonists relate to the
intemalization of their receptors?
J.A. Koenig, R. Kaur and P.P.A. Humphrey 32
7 Distribution of histamine H^-receptor binding in the normal human basal ganglia:
comparison with Huntington's disease and Parkinson's disease cases
R.E. Goodchild, J.A. Court, LHobson, M.A. Piggott, R.H. Perry, P. Ince, E. Jaros
and E.K. Perry 33
8 Molecular determinants for high-affinity binding to the vasopressin V1a receptor
S.R. Hawtin and M. Wheatley 33
9 Naloxone benzoylhydrazone inhibits K+-evoked glutamate release from rat brain slices
B. Nicol, D.J. Rowbotham, D. Smart, A.T. McKnight and D.G. Lambert 33
10 Effects ofsteroidal neuromuscular-blocking drugs on pH]noradrenaline release from
SH-SY5Y cells
T.M. Cembala, B.L. Appadu and D.G. Lambert 33
11 Gonadotropin-releasing hormone receptors with added cytoplasmic C-terminal tails
undergo accelerated (beta)-arrestin-dependent internalization
A. Heding, M. Vreci, A. Hanyaloglu, P.L. Taylor, R. Sellar, B. Byrne, G.B. Willars
and K.A. Eidne 34
12 A comparative study of growth factor receptor and G-protein-coupled receptor
phosphoinositide and Ca2+ signalling in SH-SY5Y neuroblastoma cells
L.M. Wheldon, P.J. White, S.R. Nahorski and G.B. Willars 34
13 Absence of rapid desensitization and agonist-dependent phosphorylation of the
mammalian gonadotropin-releasing hormone receptor is associated with the absence of
a cytoplasmic C-terminal tail
G.B. Willars, S.R. Nahorski, K.A. Eidne and A. Heding 34
14 Phosphorylation and functional regulation of the (beta)2-adrenergic receptor by the
phospholipase-C-coupled M^muscarinic receptor
D.C. Budd, K.W. Young, R.A.J. Challiss and A.B. Tobin 34
115 Calmodulin-dependence ofpresynaptic metabotropic glutamate receptor signalling
V. O'Connor, 0. El Far, E. Bofill-Cardona, C. Nanoff, M. Freissmuth, J.M. Airas,
H. Betz and S. Bohm 35
15 Biochemical characterization of morphological differentiation of malignant epithelial
cells induced by contact with peripheral nerve tissue
G. Cuttle and S.J. Pape 35
16 Screening for CCKA-binding inhibitors: a comparison of combinatorial chemistry
approaches
L. Clark, B. Evans, A. Pipe, S. Arpino and M. Banks 35
17 Studies with compounds that enhance the binding of [125I]-labelled ovine CRF in a
recombinant human CRF-1 receptor scintillation proximity assay
V. Shield, L. Clark, S. and M. Banks 35
18 A single amino acid (Glu-146) governs the substrate specificity of human
catecholamine sulphotransferase SULTIA3
R. Dajani, A. Hood and M. Coughtrie 36
19 Hydrogen bonding and protein pertubation in (beta)-lactam acylenzymes of Streptococcus
pneumoniae penicillin-binding protein PBP2x
A.-S. Wilkinson, C.W. Wharton, R. Chittock, S. Ward, M.G.P. Page and
J.J. Goodall 36
20 Investigation of cytochrome P-450 3A4 by surface-enhanced resonance Raman
scattering
I.D.G. MacDonald and M.P. Pritchard 36
21 Studies ondeacetoxycephalosporinCsynthase
M.D. Lloyd, H.-J. Lee, J.E. Baldwin, C.J. Schofield, J.M. Charnock and C.D. Garner 36
22 Evaluation of a kinetic approach to the determination ofcatalytic-site content in
enzymes and enzyme-like catalysts
S. Sonkaria, S. Gul, M. Resmini and K. Brocklehurst 37
23 Investigation of electrostatic and hydrogen and caricain bonding interactions of
caricain Asp-158—>Asn with time-dependent inhibitors
S. Hussain, K.K. Alien, LF. Connerton, N.J. Cummings, S. Gul, A. Khan,
M.A.J. Taylor, E.W. Thomas, C. Verma and K. Brocklehurst 37
24 Rho-GDI-Rac interaction by NMR
1. Barsukov, L.-Y. Lian, R. Badii, K.-H. Sze and G.C.K. Roberts 37
25 Structural studies of histidines in zinc (beta)-lactamases and their interactions with
inhibitors
C. Damblon, C.L.Y. Lian, R.P. Soto, M.H. Villadares, M. Galleni, J.M. Frère and
G.C.K. Roberts 37
26 Investigation of chymotrypsin-ligand complexes using IR spectroscopy: a model for
the study of (beta)-lactamases?
J.J. Goodall, A.-S. Wilkinson and C.W. Wharton 38
27 Characterization of Dictyostelium myosin II mutated in the converter region
P.A. Kubiman, N. Sasaki, R. Ohkura, K. Sutoh and C.R. Bagshaw 38
28 Kinetic mechanism of aspartate- (beta)-semialdehyde dehydrogenase and its interaction with
small molecule inhibitors
C.J. Greenwood, K.J. Moore, T. Allinson, G. Burton, C. Frydych, F. Harrington,
N. Nicholson, M. Hartley, M. Pearson and A.J. Pope 38
29 Site-directed mutagenesis in the active site of Rhodotorula gracilis D-amino-acid
oxidase
M.S. Pilone, G. Molla, C. Harris, D. Porrini, C. Vegezzi, S. Campaner and L. Pollegioni 38
30 Mechanistic insights into substrate turnover and inhibition ofmetallo-P-lactamases
M.J.B. Brown, M. Gilpin, D. Witty, J. Bateson and A.J. Pope 39
31 The structure, function and convergent evolution of intron-encoded homing
endonucleases
B.L. Stoddard, M. Jurica, P. Heath and K. Flick 39
32 3-Carbonyl-substituted glutathione conjugates as inhibitors of Onchocerca vovulus
glutathione S-transferase 2
P.M. Brophy, A.M. Cambell, A.-M. van Eldick, P.H. Teesdale-Spittle and M.F. Wang 39
114 Structure and function studies ofhydroxymethylbilane synthase using SRS and ESRF
P.F. Faulder, Y.P. Nieh, J. Raftery, J. Habash, A. Haedener, S. McSweeney,
F. Schotte, T. Ursby, M. Wuiff, A.W. Thompson and J.R. Helliwell 39
33 CD spectroscopy in hyaluronan research
G. Siligardi and R. Hussain 40
34 An N-terminal link protein peptide stimulâtes biosynthesis of collagen and
proteoglycans by explants of human articular cartilage
H. Liu, L.A. McKenna and M.F. Dean 40
35 Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan
decasaccharides and not hexasaccharides
R. Tammi, D. MacCallum, V.C. Hascall, J.-P. Pienimaki, M. Hyttinen and
M. Tammi 40
36 Epidermal growth factor regulates keratinocyte hyaluronan metabolism
J.-P. Pienimaki, R. Tammi, K. TOrroneii and M. Tammi 40
37 Characterization of trans-synovial flow plateau' caused by high-molecular-mass
hyaluronan
D. Scott, J.R. Levick, P.J. Coleman and R.M. Mason 41
38 A simple theory for concentration polarization during ultrafiltration across a partially
reflecting membrane in a stirred cell
J.R. Levick 41
39 Serum chondroitin sulphate epitopes in rheumatoid arthritis
J. Middleton, S. White, E. Parry, C. Jackson, A. Darby, J. Dixey and B. Ashton 41
40 The expression of mucin genes in Barretts oesophagus
G.S. Arul, N. Myerscough, M. Moorghen, R.D. Spicer, D. Alderson and A.P. Corfield 41
41 Regulation of the cell-surface hyaluronan receptor, CD44
P. Townsend, C. Lewis, J. Legg and C. Isacke 42
42 Recovery of mRNA from chrondocytes in agarose
Z.V. Hazlehurst, V.L. Church, S.M. Kennedy and B.A. Ashton 42
43 Co-localization of a proteoglycan epitope and type X collagen by human intervertebral
disc cells in vitro
S. Roberts, E. Johnson, B. Garguilo, B. Caterson and A. Kwan 42
44 Synthesis of hyaluronan by bacterial fermentation
C.M. Lockett and J.N. Hunter 42
45 Immunolocalization of matrix metalloproteinase-3 (stromelysin-I) in carotid artery
plaques
A.D. Khattab, J. Bowley, I.S. Ali, A. Bowley, R.R. Dils and M.Z. Rana 43
46 Hyaluronic acid fragments activate nuclear factor (NF)KB in ECV304 cells via its
principal cell-surface receptor CD44
K.A. Fitzgerald and L.A.J. CTNeill 43
48 Characterization of a Leu—>Trp mutant of the flavodehydrogenase domain of
flavocytochrome b2
R. Moysey, F. Welsh, S.K. Chapman and G.A. Reid 43
49 Bio 1: is it a cytochrome P-450?
A.J. Green, A.W. Munro, S.L. Rivers, S.K. Chapman and G.A. Reid 44
50 Determinants of substrate binding in flavocytochrome P-450 BM3
M.A. Noble, C.S. Miles, G.A. Reid, S.K. Chapman and A.W. Munro 44
51 Catalytic properties of key active-site mutants of flavocytochrome P-450 BM3
M.A. Noble, C.S. Miles, G.A. Reid, S.K. Chapman and A.W. Munro 44
52 The interaction of nitric oxide with flavocytochrome P-450 BM3
L. Quaroni, W.E. Smith, M.A. Noble and A.W. Munro 44
53 Analysis of flavocytochrome P-450 BM3 using resonance Raman spectroscopy
A.W. Munro, L. Quaroni, I.D.G. MacDonald, W.E. Smith, J. Hudecek,
V. Baumruk and P. Anzenbacher 45
54 Altering the electron acceptor specificity of flavocytochrome b2
F. Welsh, S. Rivers, S.K. Chapman and G.A. Reid 45
55 Voltammetric navigation of a flavocytochrome film
K. Thrner, M. Doherty, S. Chapman, D. Heering and F. Armstrong 45
56 Stepwise electron transfer to 6-5-cysteinyl FMN in trimethylamine dehydrogenase
J. Basran, M.-H. Jang/M.J. Sutcliffe, R. Hille and N.S. Scrutton 45
57 Substrate inhibition in wild-type and mutant trimethylamine dehydrogenases
P. Roberts, J. Basran, M. Mewies, R. Hille and N.S. Scrutton 46
58 Electron transfer in tp-hydroxylation: analysis of rubredoxin reductase and rubredoxin
H.J. Lee, J. Basran, L.-Y. Lian and N.S. Scrutton 46
59 Structure and mechanism of an opiate-transforming redox enzyme: morphinone
reductase
D.H. Craig, N.C. Bruce, P.C.E. Moody and N.S. Scrutton 46
60 Study of intramolecular electron transfer and catalytic action of quinohaemoprotein
alcohol dehydrogenase from Gluconobacter sp. 33
A. Ramanavicius, J. Razurniene, V. Laurinavicius, L. Marcinkeviciene,
1. Bachmatova, R. Meskys and R. Rudomanskis 46
61 Site-directed mutagenesis of an active-site residue in Salmonella typhimurium
dehydroquinate synthase
M.A. Skinner and K.A. Brown 47
62 Construction and expression of the truncated forms of the katG gene from
Mycobacterium tuberculosis
Jesmin, J.M. Nagy, A.E.G. Cass and K.A. Brown 47
63 Expression and preliminary purification of a Zn2+ form of Escherichia coli
dehydroquinate synthase
M. Shafiq, M.A. Skinner and K.A. Brown 47
64 Purification of 5-enolpyruvyJshikirnate-3-phosphate synthase from Haemophilus
influenzae 47
K. A. BROOWN
65 Regulation ofATP synthesis and proton handling in ischaemically exercising skeletal
muscle
G.J. Kemp, M. Roussel, D. Bendahan, Y. Lefur and P.J. Cozzone 48
66 Simulation of the epidermal growth factor signal transduction pathway
F.A. Brightman, S. Thomas and D.A, Fell 48
67 Computer simulation and evolution strategies in the study of rat heart glucose
metabolism
S. Thomas, M.G. Poolman and D.A. Fell 48
68 A role for the endogenous cannabinoid, anandamide, in the human placenta
1. Das and S.R. Sooranna 48
69 Dexamethasone administration in adulthood leads to cardiac protein kinase C
expression reminiscent of early development
M.L. Langdown, M.J. Holness and M.C. Sugden 49
70 The effect of maternal protein deficiency on the expression of the growth-arrest-
specific gene 6 (gas6) in the fetal kidney
W.D. Rees and S.M. Hay 49
71 Sulphotransferase activity in the human placenta
E.L.Stanley, M.W.H. Coughtrie and R. Hume 49
72 Effect of birth and ambient temperature on abundance of long and short forms of the
prolactin receptor in ovbrown-adipose tissue
J. Bispham, L. Heasman, L. Clarke, P. Ingleton, T. Stephenson and M.E. Symonds 49
73 Developmental changes in the appearance ofleptin in ovine adipose tissue
V. Wilson, L. Heasman, J. Dandrea, T. Stephenson and M.E. Symonds 50
74 Platelet nitric oxide synthase activity and plasma cGMP levels suggests dysregulation
in nitric oxide metabolism in schizophrenia
L Das and N.S. Khan 50
75 Regulation of the hepatic microsomal triglycéride transfer protein (MTP) gene by
dietary cholestérol is maintained in isolated hepatocytes
A.J. Bennett, H.M. Sims, A. Ford, K. Lawler, D.A. White, A.M. Salter and
M.A. Billett 50
76 The effect of oestrogen on the metabolism of chylomicron cholestérol in the rat in vivo
K.M. Botham, M. Avella, A. Cantafora and E. Bravo 50
77 The conversion of chylomicrons of different fatty acid composition into chylomicron
remnants in vivo
M.H. Rahman, M. Avella and K.M. Botham 51
78 Preparation and evaluation of an antibody to rat hepatic lipase: effect on liver
chylomicron remnant uptake
M.S. Lambert, M. Avella, Y.Berhane, E. Shervill and K.M. Botham 51
79 Effects of hypercholesterolaemia on endothelial cell function and chylomicron remnant
uptake by the rat aorta
D.J. Grieve, M.A. Avella, J. Elliott and K.M. Botham 51
80 p-Hydroxycinnamoyl-CoA hydratase/lyase: a Pseudomonas enzyme expressed in hairy
root cultures of Datura stramonium
A. Mitra, M.J. Mayer, A.J. Michael, Y. Kitamura, C. Sewter, A. Narbad, A.J. Parr
and N.J. Walton 51
81 Identification of the amylogenin gene of rice
D.A. Jackson and H.F.J. Bligh 52
82 Solute transport in Methylophilus methylotrophus
J. Mills, N. Wyborn, S. Williams, J. Greenwood and C.W. Jones 52
83 Employment of quinohaemoprotein alcohol dehydrogenase from Gluconobacter sp. 33
entrapped in polypyrrole film for creation of reagentless alcohol biosensor
A. Ramanavicius, W. Schuhmann, K. Habermuller, V. Laurinavicius,
L. Marcinkeviciene, 1. Bachmatova, L. Gorton and E. Csoregi 52
84 Biological fluids alter the surface chemistry of nanostructured silicon semiconductors
S.C. Bayliss and L.D. Buckberry 52
85 The viability of mammalian cells on nanostructured silicon semiconductors
S.C. Bayliss and L.D. Buckberry 53
86 Characterization of the interaction of prothrombin with immobilized phospholipid
membranes
R.R. Patel, J. Patel, K.A. Brown and C. LongstafT 53
87 Immunostimulatory peptides from fish waste hydrolysates
L. Gilmartin, J. Roper, R. Ravallec, A. Gildberg, E. Stenberg, J.E. Harris and L. Jervis 53
89 The effect of A (beta)-amyloid peptides on the uptake of choline and noradrenaline by the
human neuroblastoma SH-SY5Y
N.J. Webster, S. Hodges, C. Peers and P.F.T. Vaughan 53
90 Insulin-stimulated release of glycosylphosphatidylinositol-anchored proteins
S. Pang, S. Movahedi and N.M. Hooper 54
91 Proteolytic fragmentation of aminopeptidase N
L.D. Ofner and N.M. Hooper 54
92 Detergent solubility and proteolytic processing of the prion protein
A.R. Wairnsley, F. Zeng and N.M. Hooper 54
93 Use of neoepitope antibodies to study membrane processing of CD23
T.J. Wright, R.A. Maciewicz and C.R.A. Hewitt 54
94 Sequence analysis and characterization of the rat orthologue of tumour-necrosis-factor-
a-converting enzyme
A.J. Beaumont, J.A. Jury, J. Frayne, R. Devos, J. van der Heyden, L. Jeffrey,
G.J. Price and L. Hall 55
95 Role of intemalization in the regulation of phospholipase-C-coupled receptor
desensitization and resensitization
A. Rac and A.B. Tobin 55
96 The effect of poliovirus infection on mitochondrial function
A. Koundouris, C. Jonson, P.G. Sanders, G.E.N. Kass and M.J. Carter 55
97 Structure and mechanism of the bacterial protein toxin, pneumolysin
R. Gilbert, J. Rossjohn, M. Parker, T. Mitchell, A. Rowe, S. Chen, J. Jiménez,
H. Saibil, 0. Byron and P. Andrew 55
98 Phorbol-ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is
not inhibited by a disulphide-bridged stalk
S.L.U. Schwager, A.J. Chubb, R.R. Scholle, K. Naidoo, W.F. Brandt, C. Eckerskorn,
E.D. Sturrock and M.R.W. Ehlers 56
99 Evolution of hexokinases
M.L. Cardenas, A. Cornish-Bowden and T. Ureta 56
100 Ferredoxin NADP^ reductase: identification of key residues involved in NADPH
binding and electron transfer
C. Leadbeater, D.J. Campopiano, R.L. Baxter and S.P. Webster 56
101 Characterization of ferredoxin (flavodoxin) NADP^ reductase and flavodoxin; key
components of electron transfer in Escherichia coli
L. Mciver, C. Leadbeater, D.J. Campopiano, R.L. Baxter and A.W. Munro 56
102 Photo-induced internal electron transfer in nitrite reductase from Pseudomonas
aeruginosa
E.K. Wilson, A. Bellelli, P. Brzezinski, M. Arose, S. Grasso, S. Liberti, F. Cutnizzola
and M. Brunori 57
103 Cytochrome P-450 BM3: NMR, modelling, mutagenesis and substrate specificity
P. Tsan, C.F. Oliver, S. Modi, W.U. Primrose, M.J. Sutcliffe, L.Y. Lian and
G.C.K. Roberts 57
104 Kinetic analysis of a unique fumarate reductase
M.K. Doherty, S.K. Chapman and G.A. Reid 57
105 Structure-function studies on Arg-289—>Lys mutant flavocytochrome b2
C.G. Mowat, A.D. Pike, S.K. Chapman, G.A. Reid, M. Gondry and F. Lederer 57
106 Cytochromes c from Shewanella putrefaciens NCIMB400
A.E. Hill 58
107 Characterization of L-mandelate dehydrogenase from Rhodotorula graminis
D.J. Robertson 58
108 Engineering non-physiological electron transfer
S.J. Sadeghi and G. Gilardi 58
109 Mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2
(MEKK2) and MEKK3 activate both mitogen-activated protein kinase kinase 6
(MKK6) and MKK7 in intact cells
K. Deacon and J.L. Blank 58
110 The effect of protein kinase C on dynamin and endocytosis in Schi^osacchromyces
pombe
W.G.C. Horsnell, S. Fletcher and N.T. Goode 59
111 The role of calcium in muscarinic receptor activation of extracellular signal-related
protein kinase and c-Jun N-terminal kinase pathways
P.G. Wylie, R.A.J. Challiss and J.L. Blank 59
112 Vasopressin-induced translocation of SIOO proteins in renal tissue discs in vitro
S. Brant, P. Sharma and A.T. Evans 59
113 The nutritional toxicity of sweet lupin (Lupinus angustifolius) seed proteins
M.H. Rahman 59
_______________________________________
BIOCHEMICAL SOCIETY TRANSACTIONS
VOL. 27 , NO. 4 , 1999
X-Ray Structure and Reaction SYOSHIKAWA 351
Mechanism of Bovine Heart
Cytochrome c Oxidase
Small GTPases and Cell c J MARSHALL 363
Cycle Regulation
Using NMR as a Probe of J. P. G. MALTHOUSE 701
Protein Structure and
Function
The Insulin Receptor: from C.MARINO-BUSLJE,M.MARTIN-MARTINEZ 715
K. MIZUGUCHI, K. SIDDLE AND T. L. BLUNDELL
Protein Sequence to
Structure
Phospholipase-induced modulation of rat liver C. E. ROLPH, P. ROBERTS AND S. TAYLOR 371
mixed-function oxidase activity
Adaptive responses to fatty acids are mediated C. N. A. PALMER, M. C. U. GUSTAFSSON, 374
by the regulated expression of cytochromes H. DOBSON, C. VON WACHENFELDT AND
P450 C. R. WOLF
Lipid regulation of gene expression M. C. HUNT AND S. E. H. ALEXSON 378
Sphingomyelin hydrolysis and regulation of the A. H. MERRILL, JR., E. T. MORGAN, 383
expression of the gene for cytochrome P450 M. NIKOLOVA-KARAKASHIAN AND J. STEWART
The cytochrome P450 3A4 inducer M. C. WRIGHT 387
metyrapone is an activator of the human
pregnane X receptor
Identification of intracellular ceramide target M. WICKEL, M. HEINMCH, T. WEBER, 393
proteins by affinity chromatography and TID- J. BRUNNER, M. KRONKE AND S. SCHOTZE
ceramide photoaffinity labelling
Ceramide and apoptosis D. K. PERRY 399
Extracellular actions ofsphingosine I- S. PYNE, S. RAKHIT, A.-M. CONWAY, A. McKiE, 404
phosphate through endothelial differentiation P. DARROCH, R. TATE AND N. PYNE
gene products in mammalian cells: role in
regulating proliferation and apoptosis
Recent advances in the biochemistry of T. KOLTER, T. DOERING, G. WILKENING, 409
glycosphingolipid metabolism N. WERTH AND K. SANDHOFF
Gangliosides and growth factor receptor A. A. RAMPERSAUD, J. L OBUNGER, 415
regulation R.K.PONNAPPAN,R. W. BURRY AND A. J. YATES
Membrane flow, lipid sorting and cell polarity D. HOEKSTRA. M. M. P. ZEGERS AND 422
in HepG2 cells: role of a subapical S. C. D. VAN UZENDOORN
compartment
Mechanisms by which short-chain ceramides D. ALLAN, A. SHAWYER AND A. TAYLOR 428
cause apoptosis
Regulation of sphingolipid and glycosphingolipid A. H. FUTERMAN, S. A. BOLDIN, A. B. BRANN, 432
metabolism during neuronal growth and D. PELLED, I. MEIVAR-LEVY AND K ZISLING
development
colloquium: Lipoprotein(a): the Really Bad Cholesterol?
Lipoprotein(a) in health and disease H. DIEPLINGER 439
Gene structure of apolipoprotein(a) and the B. L KNIGHT 447
regulation of its expression
Role of N-linked glycans, chaperone J. WANG AND A. L WHITE 453
interactions and proteasomes in the
intracellular targeting of apolipoprotein(a)
Use of the West of Scotland Coronary A. GAW, E. A. BROWN. G. DOCHERTY AND 459
Prevention Study bio-bank to provide new I. FORD for the West of Scotland Coronary
insights into the control of plasma Prevention Study Group
lipoprotein(a) concentrations
Genetic polymorphisms of the gene for J.THILLET 463
apolipoprotein(a) and their association with
lipoprotein(a) levels and myocardial infarction
Pharmacological modification of lipoprotein(a) K. SUCKLING 466
colloquium: Glycobiology of Pathogen-Host Interactions
Bacterium-host protein-carbohydrate K.-A. KARLSSON 471
interactions and pathogenicity
Molecular basis of mucin-Pseudomonos R. RAMPHAL 474
interactions
Malaria during pregnancy: parasites, antibodies P. E. DUFFY AND M. FRIED 478
and chondroitin sulphate A
Heparan sulphate and RNA-binding motifs in U. FREVERT 482
the malaria circumsporozoite protein
Role of glycans in Plasmodium folciparum A. BARRAGAN, D. SPILLMANN, J. CARLSON AND 487
infection M. WAHLGREN
Hoemophifus influeniae lipopolysaccharide D. W. HOOD, J. C. RICHARDS AND 493
E. R. MOXON
Glycans in meningococcal pathogenesis M. VIRJI 498
Biosynthesis of the Escherichio coli K5 capsular G. GRIFFITHS, B. BARRETT. N. COOK AND 507
polysaccharide I. S. ROBERTS
Candida cell wall mannosylation: importance in N. A. R. Gow, S. BATES, A. J. P. BROWN, 512
host-fungus interaction and potential as a E. T. BUURMAN, L M. THOMSON AND
target for the development of antifungal drugs C. WESTWATER
Biological role of Tryponosoma cruzf trans- V. L. PEREIRA-CHIOCCOLA AND S. SCHENKMAN 516
sialidase
Proteophosphoglycans from Lehhmania - T. ILG.E: HAN&MAN AND Y-D. STIERHOF - 518
promastigotes and amastigotes
colloquium: Membrane Signalling Complexes
Synaptic targeting and regulation of GABA9A) N. J. BRANDON, F. K. BEDFORD, 527
receptors C. N. CONNOLLY, A. COUVE, J. T. KITTLER,
J. G. HANLEY, J. N. JOVANOVIC, J. UREN,
P. TAYLOR, P. THOMAS, T. G. SMART AND
S. J. Moss
GABA(B)eptors function as heterodimers F.H.MARSHALL,J. WHITE, M. MAIN, A. GREEN 531
AND A. WISE
The N-terminus of RAMPs is a critical S.M.FOORD, A. WISE, J. BROWN. M.J. MAIN 535
determinant of the glycosylation state and AND N. J. FRASER
ligand binding of calcitonin receptor-like
receptor
The molecular architecture of neuronal S. J. TAVALIN, R. S. WESTPHAL, M. COLLEDGE, 539
kinase/phosphatase signalling complexes L K. U\NGEBERG AND J. D. SCOTT
Control of protein phosphatase I in the P. B. ALLEN, L. HSIEH-WILSON, Z. YAN, J. FENG, 543
dendrite C. C. OUIMET AND P. GREENGARD
colloquium: Proteomics
Difference gel electrophoresis M. UNLU 547
A strategy for the characterization of protein A. SHEVCHENKO, W. ZACHARIAE AND 549
interaction networks by mass spectrometry A. SHEVCHENKO
Proteomics in pharmaceutical research and P. CUTLER, H. BIRRELL, M. HARAN, W. MAN, 555
development B. NEVILLE, S. ROSIER, M. SKEHEL AND I. WHITE
colloquium: Quinone-Binding Sites in Membrane Proteins: Structure,
Function and Applied Aspects
Generic features ofquinone-binding sites P. RICH AND N. FISHER 561
Structures of quinone-binding sites in bc(1) E. A. BERRY, Z. ZHANG, L-S. HUANG AND 565
complexes: functional implications S.-H. KIM
Probing the ubihydroquinone primary energy R. E. SHARP, A. PALMITESSA, B. R. GIBNEY, 572
conversion site in the Rhodobocter copsulotus C. C. MOSER AND P. L. DUTTON
cytochrome bCi complex
Famoxadone and oxazolidinones: potent D. B. JORDAN, K. T. KRANIS, M. A. PICOLLELLI, 577
inhibitors of cytochrome be, R. S. SCHWARTZ, J. A. STERNBERG AND
K. M. SUN
Models for structure and function in quinone- L. MURRAY, R. H. PIPES, S. F. HASTINGS AND 581
binding sites: the Escherichio coU quinol W. J. INGLEDEW
oxidase, cytochrome bo(3)
EPR studies of the possible binding sites of the T. OHNISHI, S. MAGNITSKY, L. TOULOKHONOVA, 586
cluster N2, semiquinones, and specific T. YANO, T. YAGI, D. S. BURBAEV AND
inhibitors of the NADH:quinone A.D.VINOGRADOV
oxidoreductase (complex 1)
Quinone-binding sites in membrane proteins: C. R. D. LANCASTER 591
what can we learn from the Rhodopseudomonos
viridis reaction centre?
Properties of the common inhibitor-binding J. G. OKUN, V. ZICKERMANN AND U. BRANDT 596
domain in mitochondrial NADH-
dehydrogenase (complex 1)
Biochemical aspects of N-heterocyclic P. LOMMEN 602
complex-I inhibitors with insecticidal activity
Ubiquinone and inhibitor sites in complex I: M. D. ESPOSTI AND A. GHELLI 606
one, two or three?
Structure and mechanism ofcytosolic quinone M. A. BIANCHET, C. FOSTER, M. FAIG, 610
reductases P. TALALAT AND L. M. AMZEL
colloquium: Phospholipids: Regulators of Membrane Traffic and
Signalling
Structural basis for high-affinity M. A. LEMMON 617
phosphoinositide binding by pleckstrin
homology domains
Phosphoinositide 3-kinase knockout mice: role D. A. FRUMAN, S. B. SNAPPER, C. M. YBALLE, 624
of p85(alfa) in B cell development and proliferation F. W. ALT AND L. C. CANTLEY
Phosphoinositide 3-kinase signalling: no lipids M. P. WYMANN, L. PIROLA, V. L. KATANAEV 629
AND G. BULGARELU-LEVA
Cellular expression and function of N. T. KTISTAKIS, M. MANIFAVA, J. SUGARS, K. BI 634
phospholipase Dl AND M. G. ROTH
ADP-ribosylation factor regulates spectrin A. GODI, I. SANTONE, P. PERTILE, P. MARRA, 638
skeleton assembly on the Golgi complex by G. Di TULUO, A. LUINI, D. CORDA AND
stimulating phosphatidylinositol 4,5- M. A. DE MATTEIS'
bisphosphate synthesis
ADP-ribosylation factor GTPases in signal D. JONES, B. BAX AND S. COCKCROFT 642
transduction and membrane traffic:
independent functions ?
Generation of phosphatidylinositol-specific C. L THOMAS, J. STEEL, G. D. PRESTWICH AND 648
antibodies and their characterization G. SCHIAVO
Phospholipase C(delta) and related molecules H. YAGISAWA, M. Fujii AND M. HIRATA 652
The type II PIPkins (Ptdlns5P 4-kinases): K. A. HINCHLIFFE, A. CIRUELA, J. A. MORRIS. 657
enzymes in search of a function? N. DIVECHA AND R. F. IRVINE
Regulation of early-endosome dynamics by M. J. CLAGUE, A. T. JONES, I. G. MILLS, 662
phosphatidylinositol 3-phosphate binding D. M. WALKER AND S. URBE
proteins
Regulation of endocytic membrane traffic by J.-M. GAULLIER, D. GILLOOLY, A. SIMONSEN AND 666
phosphatidylinositol 3-phosphate H. STENMARK
Lipid kinases and trons-Golgi network S. PONNAMBALAM, S. CLOUGH, C. P. DOWNES, 670
membrane dynamics J. M. LUCOCQ, H. J. MCLAUCHLAN AND
M. C. TOWLER
Phosphatidylinositol 3,5-bisphosphate: a novel S. K. DOVE, R. K. McEwEN. F. T. COOKE, 674
lipid that links stress responses to membrane P. J. PARKER AND R. H. MICHELL
trafficking events
Divergent signalling mechanisms involved in L M. FLETCHER AND J. M. TAVARE 677
insulin-stimulated GLUT4 vesicle trafficking to
the plasma membrane
Potential regulation of ADP-ribosylation factor P. J. CULLEN AND K. VENKATESWARLU 683
6 signalling by phosphatidylinositol 3,4,5-
trisphosphate
colloquium: Molecular Interactions in Complex Proteins and Nucleic
Acids
The assembly of the EcoKI type I DNA D. T. F. DRYDEN. G. D. DAVIES, I. MARTIN, 691
restriction/modification enzyme and its L M. POWELL. N. E. MURRAY, D. J. ELLIS, T. BERGE,
interaction with DNA J. M. EDWARDSON AND R. M. HENDERSON
Restriction endonuclease reactions requiring S. E. HALFORD, D. T. BILCOCK, N. P. STANFORD, 696
two recognition sites S. A. WILLIAMS, S. E. MILSOM, N. A. GORMLEY,
M. A. WATSON, A. J. BATH, M. L EMBLETON,
D. M. GOWERS, L. E. DANIELS, S. H. PARRY AND
M. D. SZCZELKUN
Peptide synthesis with modified trypsin S. GREEN AND C. 0 FAGAIN 727
Generation of non-bitter casein hydrolysates by G. O'CuiNN, R. FITZGERALD, P. BOUCHIER AND 730
using combinations of a proteinase and M. MCDONNELL
aminopeptidases
Role of matrix metalloproteinases in normal S. MCDONNELL, M. MORGAN AND C. LYNCH 734
and disease processes
The cathepsin L-like proteinases of liver fluke C. P. BRADY, A. J. DOWD, J. TORT, L. ROCHE, 740
and blood fluke parasites of the trematode B. CONDON, S. M. O'NEILL, P. J. BRINDLEY AND
genera Fasciola and Schistosoma J. P. DALTON
The expanding superfamily ofserpins: D. M. WORRALL, O. E. BLACQUE AND 746
searching for the real targets R. C. BARNES
_______________________________________
BIOCHEMICAL SOCIETY TRANSACTIONS
VOL. 27, NO. 5, 1999
MORTON LECTURE
El The need for expression expertise in solid-state NMR studies of membrane protein and
peptides: successes and wish lists
A. Watts 131
SPEAKER ABSTRACTS
SOCIETY SPECIAL COLLOQUIUM
Structure and Function of A-Domains
Speaker Session Time: Thursday 22 July, 09.15 - J6.45
A1 Structural studies of the integrin a2-l domain
J. Ernsley 131
A2 Structure and function of von Willebrand factor type A (vWF-A) domains in
complement and coagulation
S.J. Perkins 131
A3 Functional role ofA-domains in type VI collagen
C.A. Shuttleworth 131
A4 The matrilins: a growing family ofA-domain-containing proteins
M. Paulsson 132
A5 Integrin I-domains and their function
B. Leitinger 132
A6 The A-domain of a malaria protein mediates infectivity
M.R. Hollingdale 132
A7 Vitrin: the second member of a new branch of the von Willebrand factor type A
(vWF-A) superfamily
R. Mayne 132
A8 The evolution of A-domains
D.S. Tuckwell 133
HOST COLLOQUIUM
Molecular Control ofApoptosis
Speaker Session Times: Tuesday 20 July, 09,00 - 15.30
Wednesday 21 July, 09,15-15.30
B1 Control of apoptosis in cell-free systems
P.R. Clarke 133
B2 Biochemical mechanisms of nuclear changes during apoptotic execution
K. Sainejima 133
B3 Caspases and commitment to cell death
V.L. Hedge 133
B4 Mechanisms of neutrophil apoptosis and the regulation of inflammation
M. Whyte 134
B5 Epstein-Barr virus (EBV) and apoptosis: viral mimicry of cellular pathways
L.S. Young 134
B6 Death receptors, nuclear factor (NF)-KB activation and apoptosis: the potential for
therapeutic intervention
S.N. Farrow 134
B7 Poxvirus strategies to prevent apoptosis of infected cells
G.L. Smith 134
B8 Apoptosis and the MHC
T. Rich 135
B9 T cell apoptosis: mechanism and consequences
H.J.M. Brady 135
BIO Bcl-2 related proteins and cancer
G.PackhamL 135
Bll c-Jun and Bax: regulators of programmed cell death in developing neurons
J. Ham 135
B12 Suppression of apoptosis by v-AbI protein tyrosinekinase
C. Dive 136
HORMONE GROUP COLLOQUIUM
Gene Therapy: from Bench to Bedside
Speaker Session Times: Tuesday 20 July, 09.00 - 16.10
Wednesday 21 July, 09.10 - 12.50
Cl Lentivirus vectors for gene therapy
A.M.L. Lever 136
C2 Favourable expression and safety profiles with "gutless" adenoviral vectors
S. Kochanek 136
C3 Adeno-associated virus vectors; gene therapy and viral vectors, the gap is closing
R.J. Samulski 136
C4 Herpes virus vectors for gene therapy in the nervous system
D.S. Latchman 137
C5 Towards gene therapy for cystic fibrosis
C.F. Higgins 137
C6 Indefinite heart allograft survival after adenovirus-mediated gene transfer of
transforming growth factor (TGF)pH or CTLA4
I. Anegon 137
C7 Immunotherapy of autoimmune disease by gene transfer
Y. Chemajovsky 137
C8 The basic science of brain tumour gene therapy: advantages and challenges ahead
P.R. Lowenstein 138
C9 Gene transfer approaches for the treatment of neurodegenerative diseases
P. Aebischer 138
C10 Clinical trials of brain glioblastoma using retroviral vectors
D. Klatzmann 138
Cll Gene delivery to the central nervous system (CNS) using non-viral vectors
L.W. Seymour 138
C12 Targeting the hypothalamus: curing salt loss in Brattleboro rats
J.B.Uney 139
C13 Cell-type-specific expression in the pituitary: physiology and cancer treatment
M.G. Castro 139
C14 Genetic approaches to vaccination for lymphoma
R.E. Hawkins 139
MEMBRANE GROUP/MOLECULAR AND CELLULAR PHARMACOLOGY
GROUP
Expression and Purification of Membrane Proteins
Speaker Session Times: Wednesday 21 July, 08.45 - 16.55
Thursday 22 July, 09.10 - 16.25
Dl Membrane protein biosynthesis at the endoplasmic reticulum
S. High 139
D2 Expression and purification of the mitochondrial uncoupling proteins (UCPs): a
comparative study between Escherichia coli and Saccharomyces cerevisiae
B. Miroux 140
D3 Expression ofprokaryotic membrane transport proteins in Escherichia coli: successes
and failures
A. Ward 140
D4 Functional expression in Escherichia coli and purification of a G-protein-coupled
receptor for neurotensin
R. Grisshammer 140
D5 Overexpression, refolding and crystallization of an 80 kDa outer membrane iron
transporter from the outer membrane of Escherichia coli
S.K. Buchanan 140
D6 Refolding of G-protein-coupled receptors from inclusion bodies produced in
Escherichia coli
H. Kiefer 141
D7 Amplified expression and membrane reconstitution of transport protein
B. Poolman 141
D8 Characterization and purification of a plant sucrose transporter produced in
Saccharomyces cerevisiae
J. Stolz 141
D9 Heterologous expression of the human red-cell anion exchanger (Band-3; AEI)
J.D. Groves 141
D10 Purification and crystallization of His6-tagged membrane proteins produced in
transgenic tobacco
R. Flachmann 142
Dl1 The use of baculovirus vectors for the production of membrane proteins in insect cells
R.D. Possee 142
D12 Improving the expression of the serotonin transporter in insect cells by co-expression
of molecular chaperones
C.G. Tate 142
D13 Recombinant baculovirus-based functional expression of visual pigments:
optimalization of expression level, purification and reconstitution
W.J. DeGrip 142
D14 Heterologous expression ofnicotinic acetylcholine receptors in mammalian and
Drosophila cell lines: the importance of the host cell environment
N.S. Millar 143
D15 Expression and purification of rhodopsin and its mutants from stable mammalian cell
lines for NMR studies
P.J. Reeves 143
D16 Expression of seven transmembranc receptors in mammalian cells
M. Needham 143
D17 Transient expression technologies, their application and scale-up: 5-
hydroxytryptamine-3 (5HT-3) receptor case study
H. Blasey 143
SOCIETY SPECIAL COLLOQUIUM
Structure and Function ofA-Domains
Poster Session Times: Tuesday 20 July, 17.00-1830
Wednesday 21 July. 17.00 - 1830
Thursday 22 July, 10.00 - 11.00
1 Investigating the metal-ion-dependent adhesion site (MIDAS) function in collagen VI
assembly
C. Baldock, H. Fakhoury, S.G. Ball, C.A. Shuttleworth and C.M. Kicity 144
2 In vitro assembly of type VI collagen
S.G. Ball, C.M. Kielty and C.A. Shuttleworth 144
3 The collagen sequence, GFOGER, is a binding site for integrin ex I and a2 A-dornains
and fully mediates a2p I-dependent cell recognition by collagen
C.G. Knight, L.F. Morton, A.R. Peachey, D.S. Tlickwell, R.W. Parndale and M.J. Barnes 144
4 Identification of the C3B binding site in the recombinant von Willebrand factor type-A
(vWF-A) domain of complement factor B by laser desorption/ionization MS and
homology modelling
J. Hinshelwood, D.I.R. Spencer and S.J. Perkins 144
5 The A-domain of integrin aEB7 is involved in binding to E-cadherin
J.M.G. Higgins, M. Cernadas and M.B. Brenner 145
HOST COLLOQUIUM
Molecular Control of Apoptosis
Poster Session Times: Tuesday 20 July, 17.00- 18.30
Wednesday 21 July. 17.00 - 18.30
Thursday 22 July, 10.00-11.00
6 Anti-hepatotoxic activity ofcaffeic acid: a phenolic compound from Artemisia
scoparia
A.H. Gilani, K.H. Janbaz and S.A. Saced 145
7 Jun protein is involved in suppression of apoptosis during herpes simplex virus type-1
infection
G. Zachos and J. Conner 145
8 Inhibition of apoptosis by nitric oxide donors in guinea-pig gastric mucous cells
K. Johal, C.L. Potter and P.J. Hanson 145
9 4-Hydroxylphenyl retinamide-induced apoptosis in squamous cell carcinoma cells of
vulva: role of Ca2+
E. Ulukaya and E.J. Wood 146
10 Nitric-oxide-induced cell death of PC 12 cells
A. Price and G.C. Brown 146
11 Effects of nitric oxide on activity of caspases in vitro and in macrophages
V. Borutaite and G.C. Brown 146
12 The Golgi fragments during apoptosis
J.G. Pryde and A. Walker 146
13 Micro-environmental survival stimuli combine to regulate Bcl-X and Bax and suppress
drug-induced apoptosis in B lymphoma cells
S.T. Taylor, J.A. Hickman and C. Dive 147
14 v-Abl-mediated up-regulation of p21(WAF-1) in growth-arrested and proliferating myeloid
cells
S. Khanna, R. Brown, K. Ball and C. Dive 147
15 Activation of v-AbI tyrosine kinase suppresses apoptosis and regulates
phosphorylation of protein kinase B (PKB) and the pro-apoptotic protein Bad
D. James and C. Dive 147
16 Isolation and characterization ofEpstein-Barr virus (EBV) BHRFI homologues from
Herpesvirus papio
T. Williams and S. Hazlewood 147
17 Isolation and characterization of apoptosis-controlling genes from primate
herpesviruses
M. Howell and S. Hazlewood 148
HORMONE GROUP COLLOQUIUM
Gene Therapy: from Bench to Bedside
Poster Session Times: Tuesday 20 July, J7.00 - 18.30
Wednesday 21 July, 17.00 - 18.30
Thursday 22 July, 10.00 - 11.00
18 Poster withdrawn
148
19 A physiologically regulated adenoviral vector for the treatment ofischaemic disease
K. Binley, L. Griffiths, S. lqball, H. Spearman, S.M. Kingsman, A. Kingsman and S. Naylor 148
20 Development of retroviral transduced haematopoietic stem cells towards a novel
approach to cancer gene therapy
J.S. Freeth, S. lqball, J. Rohll, S. Watt, C.E. Lewis, S.M. Kingsman and S, Naylor 148
21 A gene transfer strategy to manipulate nitric oxide in the vasculature of a hypertensive
rat model
M.Y. Alexander, M.J. Brosnan, J. Fennell, A.M. Deviin, C.A. Hamilton and A.F. Dominiczak 149
MEMBRANE GROUP COLLOQUIUM
Expression and Purification of Membrane Proteins
Poster Session Times: Tuesday 20 July, 17.00 - 18.30
Wednesday 21 July, 17.00 - 18.30
Thursday 22 July, 10.00 - 11.00
22 Comparative study of purine transporters in drug-sensitive and drug-resistant
Trypanosoma equiperdum
J.E. Leadsham and S.M. Jarvis 149
23 Transport of purine nucleobases by COS-1 cells occurs via a nitrobenzylthioinosine-
insensitive (ei) nucleoside transporter
D. Johnson and S.M. Jarvis 149
24 Characterization of purine transporters in L6 rat skeletal-muscle cells
H.L. Maddock, S. Vine, J.D. Pearson and S.M. Jarvis 149
25 Expression of isotopically labelled membrane transport proteins
H. Venter, R.B. Herbert, P.J.R. Spooner, A. Watts and P.J.F. Henderson 150
26 Overexpression, purification and structural analysis of the Escherichia coli L-fucose-H+
membrane transport protein, FucP
J. Clough and P.J.F. Henderson 150
27 In vitro expression and metabolism ofpresenilin-I protein
C. Houghton, J. Arnold, M. Shearman, S. Dawson, M. Landon, R.J. Mayer and R. Layficid 150
28 Multiplex TaqMan(r) combined reverse transcriptase (RT)-PCR: a novel method for the
quantification ofmRNA levels in receptor-transfected mammalian cell clones
P.R. Murdock, K.B. Tan, N.C. Herrity, G.L Rennie and 0. Jenkins 150
29 Electrochemical detection of secreted placental alkaline phosphatase
E. Kelso, J. McLean and M. Cardosi 151
30 Optimization of human fi opioid receptor expression in baculovirus-infected insect
cells
D. Massotte, L. Baroche, C. Pereira, T. Suply, B. Perret, B. KiefFer and F. Pattus 151
31 Expression of human a2C2-adrenergic receptor in different host-vector systems
H. Heimo, V.-P. Jaakola, A. Kapat, P. Heikinheimo, M. Rantanen, T. Glurnoffand A. Goidman 151
BIOCHEMICAL IMMUNOLOGY GROUP
Poster Session Times: Tuesday 20 July, 17.00- 18.30
Wednesday 21 July. 17.00- 18.30
Thursday 22 July, 10.00 - 11.00
32 Effect of rabbit lgG anti-xanthine oxidoreductase antibodies on NADH and oxidase
activities of human and bovine xanthine oxidoreductase
H. Djellili, F. Larguet, L. Arrar and M. Benboubetra 151
33 Studies on semen and anti-sperm antibodies in male infertility
N. Alam and M.A. Rahman 152
MOLECULAR ENZYMOLOGY GROUP
Poster Session Times: Tuesday 20 July, 17.00 - 18.30
Wednesday 21 July, 17.00 - 18.30
Thursday 22 July, 10.00 - 11.00
34 Kinetic inhibition studies of xanthine oxidase activity of both human and bovine milk
xanthine oxidase (XO) by allopurinol, alloxanthine and uric acid
F. Larguet, H. Djellili, A. Baghiani and M. Benboubetra 152
NEUROSCIENCE GROUP
Poster Session Times: Tuesday 20 July, 17.00- 18.30
Wednesday 21 July, 17.00 - 18.30
Thursday 22 July, 10.00 - 11.00
35 Astrocytes release and preserve antioxidants: implications for neuroprotection
R. Stone, V.C.Stewart,R.D. Hurst, J.B. dark and S.J.R.Heales 152
NUCLEIC ACIDS AND MOLECULAR BIOLOGY GROUP
Poster Session Times: Tuesday 20 July, 17.00-18.30
Wednesday 21 July. 17.00-18.30
Thursday 22 July, 10.00 - 11.00
36 Selective inhibition ofphlebo-, retro-, flavo- and pox-viruses by nucleoside and PFA
analogues
J.M. Bailey and K. Nelson 152
PROTEIN AND PEPTIDE SCIENCE GROUP
Poster Session Times: Tuesday 20 July, 17.00-18.30
Wednesday 21 July, 17.00 - 18.30
Thursday 22 July, 10.00 - 11.00
37 The decrease of tabtoxin produced by Pseudomonas fabaci in batch culture
D. Harzallah and L. Larous 153
Speakers' papers will be published in Biochemical Society Transactions
volume 27, part 6 (December 1999)
_______________________________________